8-K//Current report
Helix Acquisition Corp. II 8-K
Accession 0001213900-25-071392
$BBOTCIK 0001869105operating
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:45 PM ET
Size
241.5 KB
Accession
0001213900-25-071392
Documents
- 8-Kea0251413-8k425_helix2.htmPrimary
CURRENT REPORT
- EX-101.SCHhlxb-20250804.xsd
XBRL SCHEMA FILE
- EX-101.LABhlxb-20250804_lab.xml
XBRL LABEL FILE
- EX-101.PREhlxb-20250804_pre.xml
XBRL PRESENTATION FILE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001213900-25-071392-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLea0251413-8k425_helix2_htm.xml
IDEA: XBRL DOCUMENT
Issuer
BridgeBio Oncology Therapeutics, Inc.
CIK 0001869105
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001869105
Filing Metadata
- Form type
- 8-K
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:45 PM ET
- Size
- 241.5 KB